Compagnie Lombard Odier SCmA’s Medicines Co MDCO Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,000	Closed	-$170K	–	585
2019 Q4	$170K	Sell	2,000 -2,000	-50%	-$133K	0.01%	268
2019 Q3	$200K	Buy	+4,000	New	+$160K	0.01%	245

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Compagnie Lombard Odier SCmA's MDCO Position: Q1 2020 in Review

Compagnie Lombard Odier SCmA sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 2,000 shares — an estimated $170K sold.

Compagnie Lombard Odier SCmA first reported a position in MDCO in Q3 2019 and held it in 2 quarters. The position peaked at $200K in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Compagnie Lombard Odier SCmA reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 2,000 Medicines Co shares in Q1 2020, an estimated $170K.
Compagnie Lombard Odier SCmA first reported a position in Medicines Co in Q3 2019 and held it in 2 quarters.
Compagnie Lombard Odier SCmA's Medicines Co position peaked at $200K in Q3 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2020, filed 13 May 2020.